The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
mRNA Cancer Vaccines and Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global mRNA Cancer Vaccines and Therapeutics market size is expected to reach US$ 480.9 million by 2029, growing at a CAGR of 19.0% from 2023 to 2029. The market is mainly driven by the significant applications of mRNA Cancer Vaccines and Therapeutics in various end use industries. The expanding demands from the Infectious Disease, Cancer and Others,, are propelling mRNA Cancer Vaccines and Therapeutics market. Adeno Carcinomas, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mucinous Carcinomas segment is estimated at % CAGR for the next seven-year period.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for mRNA Cancer Vaccines and Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global mRNA Cancer Vaccines and Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global mRNA Cancer Vaccines and Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, mRNA Cancer Vaccines and Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of mRNA Cancer Vaccines and Therapeutics covered in this report include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc.
The global mRNA Cancer Vaccines and Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Global mRNA Cancer Vaccines and Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global mRNA Cancer Vaccines and Therapeutics market, Segment by Type:
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Global mRNA Cancer Vaccines and Therapeutics market, by Application
Infectious Disease
Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of mRNA Cancer Vaccines and Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global mRNA Cancer Vaccines and Therapeutics market size is expected to reach US$ 480.9 million by 2029, growing at a CAGR of 19.0% from 2023 to 2029. The market is mainly driven by the significant applications of mRNA Cancer Vaccines and Therapeutics in various end use industries. The expanding demands from the Infectious Disease, Cancer and Others,, are propelling mRNA Cancer Vaccines and Therapeutics market. Adeno Carcinomas, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mucinous Carcinomas segment is estimated at % CAGR for the next seven-year period.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for mRNA Cancer Vaccines and Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global mRNA Cancer Vaccines and Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global mRNA Cancer Vaccines and Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, mRNA Cancer Vaccines and Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of mRNA Cancer Vaccines and Therapeutics covered in this report include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc.
The global mRNA Cancer Vaccines and Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Global mRNA Cancer Vaccines and Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global mRNA Cancer Vaccines and Therapeutics market, Segment by Type:
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Global mRNA Cancer Vaccines and Therapeutics market, by Application
Infectious Disease
Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of mRNA Cancer Vaccines and Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of mRNA Cancer Vaccines and Therapeutics
1.1 mRNA Cancer Vaccines and Therapeutics Market Overview
1.1.1 mRNA Cancer Vaccines and Therapeutics Product Scope
1.1.2 mRNA Cancer Vaccines and Therapeutics Market Status and Outlook
1.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (2018-2029)
1.4 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, mRNA Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2018-2029)
2 mRNA Cancer Vaccines and Therapeutics Market by Type
2.1 Introduction
2.1.1 Adeno Carcinomas
2.1.2 Mucinous Carcinomas
2.1.3 Adenosquamous Carcinomas
2.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Type (2018-2029)
3 mRNA Cancer Vaccines and Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Infectious Disease
3.1.2 Cancer
3.1.3 Others
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Breakdown by Application (2018-2029)
4 mRNA Cancer Vaccines and Therapeutics Competition Analysis by Players
4.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2022)
4.3 Date of Key Players Enter into mRNA Cancer Vaccines and Therapeutics Market
4.4 Global Top Players mRNA Cancer Vaccines and Therapeutics Headquarters and Area Served
4.5 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 mRNA Cancer Vaccines and Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Moderna Therapeutics
5.1.1 Moderna Therapeutics Profile
5.1.2 Moderna Therapeutics Main Business
5.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Moderna Therapeutics Recent Developments
5.2 CureVac
5.2.1 CureVac Profile
5.2.2 CureVac Main Business
5.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 CureVac Recent Developments
5.3 Translate Bio
5.3.1 Translate Bio Profile
5.3.2 Translate Bio Main Business
5.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 BioNTech Recent Developments
5.4 BioNTech
5.4.1 BioNTech Profile
5.4.2 BioNTech Main Business
5.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 BioNTech Recent Developments
5.5 Sangamo Therapeutics
5.5.1 Sangamo Therapeutics Profile
5.5.2 Sangamo Therapeutics Main Business
5.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Sangamo Therapeutics Recent Developments
5.6 Argos Therapeutics
5.6.1 Argos Therapeutics Profile
5.6.2 Argos Therapeutics Main Business
5.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Argos Therapeutics Recent Developments
5.7 In-Cell-Art
5.7.1 In-Cell-Art Profile
5.7.2 In-Cell-Art Main Business
5.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 In-Cell-Art Recent Developments
5.8 eTheRNA
5.8.1 eTheRNA Profile
5.8.2 eTheRNA Main Business
5.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 eTheRNA Recent Developments
5.9 Ethris
5.9.1 Ethris Profile
5.9.2 Ethris Main Business
5.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Ethris Recent Developments
5.10 Tiba Biotechnology
5.10.1 Tiba Biotechnology Profile
5.10.2 Tiba Biotechnology Main Business
5.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Products, Services and Solutions
5.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Tiba Biotechnology Recent Developments
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 mRNA Cancer Vaccines and Therapeutics Market Dynamics
11.1 mRNA Cancer Vaccines and Therapeutics Industry Trends
11.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
11.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
11.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
